17 results
Relapse prevention with cariprazine in patients with early-stage schizophrenia
-
- Journal:
- European Psychiatry / Volume 67 / Issue S1 / April 2024
- Published online by Cambridge University Press:
- 27 August 2024, p. S291
-
- Article
-
- You have access
- Open access
- Export citation
The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders
-
- Journal:
- European Psychiatry / Volume 67 / Issue S1 / April 2024
- Published online by Cambridge University Press:
- 27 August 2024, p. S215
-
- Article
-
- You have access
- Open access
- Export citation
Predominant negative symptoms: views of patients vs. doctors in a 1-year observational study
-
- Journal:
- European Psychiatry / Volume 67 / Issue S1 / April 2024
- Published online by Cambridge University Press:
- 27 August 2024, pp. S171-S172
-
- Article
-
- You have access
- Open access
- Export citation
The management of patients with predominant negative symptoms in Slovakia: A 1-year longitudinal, prospective, multicentric cohort study
-
- Journal:
- European Psychiatry / Volume 67 / Issue 1 / 2024
- Published online by Cambridge University Press:
- 23 May 2024, e44
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Defining the therapeutic reference range for cariprazine
-
- Journal:
- European Psychiatry / Volume 66 / Issue S1 / March 2023
- Published online by Cambridge University Press:
- 19 July 2023, p. S559
-
- Article
-
- You have access
- Open access
- Export citation
Benzodiazepine use during cariprazine treatment in acute schizophrenia
-
- Journal:
- European Psychiatry / Volume 65 / Issue S1 / June 2022
- Published online by Cambridge University Press:
- 01 September 2022, p. S98
-
- Article
-
- You have access
- Open access
- Export citation
Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
-
- Journal:
- European Psychiatry / Volume 65 / Issue S1 / June 2022
- Published online by Cambridge University Press:
- 01 September 2022, pp. S156-S157
-
- Article
-
- You have access
- Open access
- Export citation
The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
-
- Journal:
- European Psychiatry / Volume 65 / Issue S1 / June 2022
- Published online by Cambridge University Press:
- 01 September 2022, p. S323
-
- Article
-
- You have access
- Open access
- Export citation
The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 1 / February 2023
- Published online by Cambridge University Press:
- 10 December 2021, pp. 104-111
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Disentangling the symptoms of schizophrenia: Network analysis in acute phase patients and in patients with predominant negative symptoms
- Part of
-
- Journal:
- European Psychiatry / Volume 65 / Issue 1 / 2022
- Published online by Cambridge University Press:
- 13 October 2021, e18
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials
-
- Journal:
- European Psychiatry / Volume 64 / Issue S1 / April 2021
- Published online by Cambridge University Press:
- 13 August 2021, pp. S524-S525
-
- Article
-
- You have access
- Open access
- Export citation
The effect of cariprazine on patient engagement: Post-hoc analysis of a phase 3 study in patients with predominant negative symptoms of schizophrenia
-
- Journal:
- European Psychiatry / Volume 64 / Issue S1 / April 2021
- Published online by Cambridge University Press:
- 13 August 2021, p. S533
-
- Article
-
- You have access
- Open access
- Export citation
Safety during polypharmacy: A post-hoc analysis examining the safety profile of cariprazine with other antipsychotics in the cross-titration phase
-
- Journal:
- European Psychiatry / Volume 64 / Issue S1 / April 2021
- Published online by Cambridge University Press:
- 13 August 2021, pp. S533-S534
-
- Article
-
- You have access
- Open access
- Export citation
Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial
-
- Journal:
- European Psychiatry / Volume 33 / Issue S1 / March 2016
- Published online by Cambridge University Press:
- 23 March 2020, pp. s256-s257
-
- Article
-
- You have access
- Export citation
Day-to-day and Social Functioning of Patients with Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Phase 3 Clinical Trial with Cariprazine Monotherapy and Risperidone
-
- Journal:
- European Psychiatry / Volume 41 / Issue S1 / April 2017
- Published online by Cambridge University Press:
- 23 March 2020, p. S270
-
- Article
-
- You have access
- Export citation
Diagnosis of Predominant Negative Symptoms: Post-hoc Analyses of a Phase 3 Clinical Trial with Cariprazine Monotherapy and Risperidone
-
- Journal:
- European Psychiatry / Volume 41 / Issue S1 / April 2017
- Published online by Cambridge University Press:
- 23 March 2020, p. S270
-
- Article
-
- You have access
- Export citation
The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors
-
- Journal:
- European Psychiatry / Volume 58 / May 2019
- Published online by Cambridge University Press:
- 07 February 2019, pp. 1-9
-
- Article
-
- You have access
- Open access
- HTML
- Export citation